These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2080305)

  • 1. [The Second Questionnaire Report of Safety Control on Instruments in a Nuclear Medicine Laboratory. Subcommittee of Nuclear Medicine Technology, Medical and Pharmaceutical Committee, Japan Radioisotope Association].
    Radioisotopes; 1990 Nov; 39(11):521-35. PubMed ID: 2080305
    [No Abstract]   [Full Text] [Related]  

  • 2. [Questionnaire report of safety control on instrument in nuclear medicine laboratory. Subcommittee of Nuclear Medicine Technology, Medical and Pharmaceutical Committee, Japan Radioisotope Association].
    Radioisotopes; 1987 Sep; 36(9):484-99. PubMed ID: 3423318
    [No Abstract]   [Full Text] [Related]  

  • 3. [The present state of nuclear medicine practice in Japan--a report of the 2d nationwide survey in 1987. Subcommittee for Surveillance of Nuclear Medicine Practice, Medical and Pharmaceutical Committee, Japan Radioisotope Association].
    Radioisotopes; 1989 Apr; 38(4):219-28. PubMed ID: 2740536
    [No Abstract]   [Full Text] [Related]  

  • 4. Nuclear medicine practice in Japan: a report of the sixth nationwide survey in 2007.
    Kuwabara Y; Koizumi K; Ushijima Y; Kinuya S; Kinomura S; Suga K; Takeoka H; Takeda T; Toyama H; Arao Y; Nishiyama Y; Murakami K; Morita K
    Ann Nucl Med; 2009 Feb; 23(2):209-15. PubMed ID: 19225946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICANL and ACR nuclear medicine accreditation: a comparison.
    Wackers FT
    J Nucl Med; 2000 May; 41(5):26N-8N. PubMed ID: 10841666
    [No Abstract]   [Full Text] [Related]  

  • 6. [A guideline for clinical application of radiolabeled monoclonal antibodies produced in individual medical research laboratories. Subcommittee on Medical Application of Radiolabeled Monoclonal Antibodies, Medical and Pharmaceutical Committee, Japan Radioisotope Association].
    Radioisotopes; 1990 Dec; 39(12):597-9. PubMed ID: 2291000
    [No Abstract]   [Full Text] [Related]  

  • 7. [The 10th Quality Control Survey for Radioisotope in vitro Tests in Japan, 1988. Subcommittee for Radioisotope in vitro Test, Medical and Pharmaceutical Committee, Japan Radioisotope Association].
    Radioisotopes; 1989 Oct; 38(10):i-xxvii. PubMed ID: 2813858
    [No Abstract]   [Full Text] [Related]  

  • 8. Intercomparison of activity measurements for beta-emitters in Swiss nuclear medicine laboratories.
    Wastiel C; Valley JF; Delaloye AB; Leresche M; Linder R; Sassowsky M; Bochud FO
    J Nucl Med Technol; 2005 Dec; 33(4):238-42. PubMed ID: 16322126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations for a pediatric dose in nuclear imaging. Subcommittee for Standardization of Radionuclide Imaging, Medical and Pharmaceutical Committee: Japan Radioisotope Association].
    Radioisotopes; 1988 Nov; 37(11):627-32. PubMed ID: 3222473
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biohazard control in the research laboratory].
    Sato M; Hosotani R
    Nihon Geka Hokan; 1983 Sep; 52(5):648-54. PubMed ID: 6675537
    [No Abstract]   [Full Text] [Related]  

  • 11. [Validation of the ISO 15189 trial assessment results of clinical laboratories--effects of accreditation and interpretation of ISO 15189].
    Aoyagi T; Kawai T
    Rinsho Byori; 2006 May; 54(5):486-93. PubMed ID: 16789419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Are the Norwegian nuclear medicine laboratories good enough? A report from a nationwide quality control survey of nuclear medicine instruments performed by the Norwegian Society for Nuclear Medicine and the National Institute for Radiation Protection].
    Rootwelt K; Skretting A; Bjørnerud T; Boye E; Berthelsen T; Hertzenberg L; Nerdrum HJ; Falch D; Bremer PO
    Tidsskr Nor Laegeforen; 1985 Oct; 105(28):1978-81. PubMed ID: 4071490
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse reactions to radiopharmaceuticals: incidence in 1978, and associated symptoms. Report of the Adverse Reactions Subcommittee of the Society of Nuclear Medicine.
    Rhodes BA; Cordova MA
    J Nucl Med; 1980 Nov; 21(11):1107-10. PubMed ID: 7431113
    [No Abstract]   [Full Text] [Related]  

  • 14. A practical guide to quality improvement in nuclear medicine.
    Farrell MB; Abreu SH
    J Nucl Med Technol; 2012 Dec; 40(4):211-9. PubMed ID: 23071346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mayo Clinic approaches to meet United States Pharmacopeia <797> requirements for facility design and environmental controls of nuclear pharmacy.
    Hung JC; Anderson MM
    J Nucl Med; 2009 Jan; 50(1):156-64. PubMed ID: 19091891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control and quality assessment of coagulation tests in Japan.
    Matsuno K; Yasushi T
    Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():99-103. PubMed ID: 12755278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the SNM Committee on Pharmacopeia: Exemption of radiopharmaceuticals from <797>.
    Hung JC;
    J Nucl Med; 2004 Oct; 45(10):13N, 16N. PubMed ID: 15551509
    [No Abstract]   [Full Text] [Related]  

  • 18. [Some thoughts on nuclear medicine].
    Irie H
    Rinsho Hoshasen; 1977 May; 22(5):521-5. PubMed ID: 559178
    [No Abstract]   [Full Text] [Related]  

  • 19. Establishment of a national program for quality control of nuclear medicine instrumentation.
    Coca Perez MA; Torres Aroche LA; Bejerano GL; Mayor RF; Corona CV; López A
    J Nucl Med Technol; 2008 Dec; 36(4):203-6. PubMed ID: 19008290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear medicine: guidelines for the provision of a clinical service. Report of a Working Group of the Royal College of Physicians Nuclear Medicine Committee.
    J R Coll Physicians Lond; 1997; 31(4):384-8. PubMed ID: 9263965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.